© 2019 Hylomorph AG

Hylomate is a registered trademark - all rights reserved

Privacy Policy

  • LinkedIn Social Icon
Transforming the biocompatibility of tissue implants

Tens of millions of people live today with one or more surgical implant. Every time a patient receives a surgical implant, the immune system initiates a foreign body reaction. The implant becomes covered by a thick layer of fibrotic tissue, which hardens and contracts over time in an attempt of isolating, killing and expelling the foreign body.

‚Äč

Hylomorph has developed a unique technology providing an optimal biocompatible barrier between soft tissues and implantable medical devices, reducing fibrotic tissue build up and associated clinical complications.

CellSense.jpg

Technology

The  CellSense  technology  combines material science, bio- and micro-engineering  designed  to  interfere  with  the  complex  biological response involved in the foreign body reaction and subsequent formation of fibrotic tissue around the implantable medical device. 

zz_77K5178corr.jpg

Products

adults-analysis-brainstorming-1661004.jp

Collaborate

Hylomate is a product platform developed to resolve a number of clinical unmet needs. Hylomorph's lead development program aims to prevent implantable pulse generator revision surgery complications linked to surgical pocket fibrosis.

Hylomorph offers medical device implant manufacturers a state-of-the-art surface science to be integrated into new or existing products in order to enhance their long term safety and performance.